Innovation & Tech

Credo Health Buys Affineon, Relaunches as Pajama.ai to Attack After-Hours Physician Work

Credo Health acquires Affineon Health and relaunches as Pajama.ai, an AI platform claiming to return 40 hours monthly to physicians by automating EHR admin work.

By Amara Osei

3 min read

Credo Health Acquires Affineon Health And Relaunches As Pajama.ai
Credo Health Acquires Affineon Health And Relaunches As Pajama.aiAI-generated

What's News

  • Credo Health acquired Affineon Health and relaunched as Pajama.ai, targeting 40 hours/month of physician admin time savings.
  • The combined platform serves 200+ clinical groups, 3,000 physicians and 5 million patients.
  • Pajama automates 40-60% of inbox messages and cuts chart prep time by 3-5 minutes per patient.
  • Carm Huntress remains CEO; Affineon's Evan Grossman becomes Chief Product Officer.
  • Pajama debuts at HLTH 2026 in Las Vegas on a monthly subscription model.

Credo Health has acquired Affineon Health and relaunched the combined company as Pajama.ai, an AI platform that says it can hand physicians back roughly 40 hours per month by cutting chart prep, lab results, prescription renewals and other EHR work.

The name comes from "pajama time" — the after-hours admin work doctors finish from home after clinical hours end. The deal merges Credo's medical record retrieval and clinical insight technology with Affineon's workflow automation into a single platform that plugs directly into existing EHR workflows.

Credo co-founder Carm Huntress stays on as CEO. He previously founded Arrive Health, whose real-time prescription drug pricing technology is used by roughly 600,000 healthcare providers. Affineon CEO Evan Grossman becomes Chief Product Officer and will run the combined product roadmap.

What does the combined platform actually do?

Credo's side retrieves and organizes longitudinal patient records before visits, then analyzes them to flag clinically relevant information: suspected conditions, care gaps, medication issues, overdue screenings and abnormal trends.

Affineon's automation layer handles the post-visit stack — lab results, prescription renewals and encounter workflows. Together, the system can prepare charts, communicate normal test results to patients and de-duplicate prescription renewal requests.

Across the combined customer base, Pajama serves more than 200 clinical groups, 3,000 physicians and 5 million patients. The company says its technology automates between 40% and 60% of inbox messages and cuts chart preparation time by three to five minutes per patient.

"Every doctor I know has a version of the same story: dinner, the kids go to bed, and then the laptop comes out," Huntress said. "Credo helped providers walk into the exam room ready, while Affineon helped them stay caught up afterward. Together, we're giving providers a solution to the grueling hours of pajama time and giving them the time back that they deserve."

How are customers responding?

Two early users reported measurable gains. Leslie Chiang, DO, of Peachtree Medical Center, said the pre-visit insights change clinical decisions immediately.

"I honestly don't want to see patients without it now," Chiang said. "The insights provided often change my management on the spot, and I no longer have to wait on records that may never come."

Mia M. Painter, DNP, APRN, FNP-C, Chief Operating Officer of San Marcos Family Medicine, reported a sharper number: "Since implementation, we've seen over a 50% reduction in our inbox volume across the board. This has been the best product implementation we've had in years, delivering real impact, efficiency, and improved patient care."

What changes for Affineon's installed base?

Grossman moved to reassure existing Affineon customers that the deal won't disrupt their tools. "Affineon customers won't see anything change in the tools they rely on today. They'll just have more of their day back," he said. "The difference now is that we can bring Chart Prep to every practice already using our inbox automation, so providers are covered before and after the visit."

The pitch is continuity with an expanded footprint: inbox automation stays, and Credo's chart preparation layer extends across the full Affineon base.

What comes next?

Pajama will sell through a monthly subscription model. The company is scheduled to debut publicly at HLTH 2026 in Las Vegas, where it will pitch a before-and-after-visit automation stack to a healthcare industry still wrestling with documented physician burnout tied to EHR burden.

With 5 million patients already in its footprint and a founder who has scaled provider-facing software to 600,000 users before, Pajama enters that debut with an installed base most health AI startups would spend years building.

Source: pulse2.com

Share this article:

More from Amara Osei

Amara Osei

Show full bio

Senior reporter covering companies, deals and strategy in entrepreneurship, startups and venture funding at Business Bearings.

2,136 articles

Related articles

« Previous articleNext article »